Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-free rabbit anti-T-lymphocyte globulin, tacrolimus, and mycophenolate after first deceased-donor kidney transplant
2005-004431-21Phase 3Completed
- Sponsor
- Fresenius
- Start
- Dec 2005
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ATeGe, tacrolimus and mycophenolate in kidney transplant (2 arms), sponsored by Fresenius. Primary endpoints: Biopsy-proven acute rejection and Biopsy-proven subclinical acute rejection. Started Dec 2005; status: completed.
02
Drugs
ATeGetacrolimusmycophenolate
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2005-004431-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004431-21.